The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon

Global cancer statistics

2011 • 55,498 citations

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1999 • 8,737 citations

Van Damme A.

1986 • 3,477 citations

The causal relation between human papillomavirus and cervical cancer

2002 • 3,451 citations

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

2010 • 2,440 citations

Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions

2007 • 2,003 citations

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

2007 • 1,829 citations

Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update

2007 • 1,654 citations

Centers for Disease Control and Prevention (CDC) : Advisory Committee on Immunization Practices (ACIP) : Quadrivalent human papillomavirus vaccine : recommendations of the Advisory Committee on Immunization Practices (ACIP)

2007 • 1,644 citations

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

2009 • 1,580 citations

Global Burden of Human Papillomavirus and Related Diseases

2012 • 1,514 citations

Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings

2010 • 1,431 citations

Epidemiology of Genital Human Papillomavirus Infection

1997 • 1,122 citations

Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males

2011 • 1,043 citations

HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia

2011 • 877 citations

Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study

2011 • 822 citations

Human Papillomaviruses and Their Possible Role in Squamous Cell Carcinomas

1977 • 708 citations

EPIDEMIOLOGY OF GENITAL HUMAN PAPILLOMAVIRUS INFECTION

1988 • 700 citations

Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis

2008 • 675 citations

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

2011 • 654 citations

Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting Infection

2007 • 652 citations

Surveillance for certain health behaviors among states and selected local areas--Behavioral Risk Factor Surveillance System, United States, 2003.

2005 • 593 citations

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

2007 • 566 citations

Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease

2006 • 527 citations

Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.

2014 • 510 citations

Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine

2009 • 461 citations

Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data

2013 • 403 citations

International incidence rates of invasive cervical cancer after introduction of cytological screening.

1997 • 398 citations

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

2010 • 397 citations

Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-Analysis

2008 • 387 citations

Epidemiology of Human Papillomavirus Infection in Men, Cancers other than Cervical and Benign Conditions

2008 • 387 citations

National and state vaccination coverage among adolescents aged 13-17 years--United States, 2012.

2013 • 375 citations

A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

2009 • 312 citations

Immunotherapy Against HPV16/18 Generates Potent T _H 1 and Cytotoxic Cellular Immune Responses

2012 • 270 citations

Fall in Human Papillomavirus Prevalence Following a National Vaccination Program

2012 • 254 citations

Manual for the surveillance of vaccine-preventable diseases

2011 • 248 citations

Reducing HPV-Associated Cancer Globally

2012 • 227 citations

The Health and Economic Burden of Genital Warts in a Set of Private Health Plans in the United States

2003 • 223 citations

Epidemiology of recurrent respiratory papillomatosis

2010 • 204 citations

Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine

2012 • 183 citations

Genital Warts Among 18- to 59-Year-Olds in the United States, National Health and Nutrition Examination Survey, 1999–2004

2008 • 149 citations

Incidence and Prevalence of Recurrent Respiratory Papillomatosis among Children in Atlanta and Seattle

2000 • 146 citations

Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis

2012 • 130 citations

Female human papillomavirus (HPV) vaccination: Global uptake and the impact of attitudes

2013 • 125 citations

Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England

2013 • 119 citations

Modeling Preventative Strategies against Human Papillomavirus-Related Disease in Developed Countries

2012 • 105 citations

Epidemiologic Approaches to Evaluating the Potential for Human Papillomavirus Type Replacement Postvaccination

2013 • 97 citations

HPV and cervical cancer: screening or vaccination?

2008 • 91 citations

CDC grand rounds: Reducing the burden of HPV-associated cancer and disease.

2014 • 87 citations

The India HPV-vaccine suspension

2010 • 83 citations

Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine

2013 • 78 citations

TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers

2012 • 77 citations

Declining Rates of High-Grade Cervical Lesions in Young Women in Connecticut, 2008–2011

2013 • 55 citations

The Road Ahead for Cervical Cancer Prevention and Control

2014 • 54 citations

Development and Implementation of Papillomavirus Prophylactic Vaccines

2014 • 46 citations

Human Papillomavirus and Cancer Prevention: Gaps in Knowledge and Prospects for Research, Policy, and Advocacy

2012 • 44 citations

Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine

2010 • 44 citations

Human papillomavirus: science and technologies for the elimination of cervical cancer

2011 • 43 citations

Understanding genital warts: epidemiology, pathogenesis, and burden of disease of human papillomavirus.

2013 • 41 citations

Control of HPV Infection and Related Cancer Through Vaccination

2013 • 38 citations

A cost-utility analysis of cervical cancer vaccination in preadolescent Canadian females

2009 • 38 citations

For Cancers Caused by HPV, Two Vaccines Were Just the Beginning

2011 • 30 citations

Cervarix®: a bivalent vaccine against HPV types 16 and 18, with cross-protection against other high-risk HPV types

2012 • 29 citations

New Approaches to Prophylactic Human Papillomavirus Vaccines for Cervical Cancer Prevention

2011 • 27 citations

Evaluation of a Cervical Cancer Screening Program Based on HPV Testing and LLETZ Excision in a Low Resource Setting

2010 • 21 citations

Provinces weighing HPV vaccination of boys

2012 • 16 citations

Annual disease burden due to human papillomavirus 16 and 18 infections in Finland

2009 • 16 citations

Prevalence of Cervical Human Papillomavirus (HPV) Infection in Vanuatu

2012 • 15 citations

Role and uptake of human papillomavirus vaccine in adolescent health in the United States

2011 • 15 citations

HPV vaccination programs have not been shown to be cost-effective in countries with comprehensive Pap screening and surgery

2013 • 13 citations

Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland

2009 • 12 citations

Social and psychological aspects of cervical screening

2010 • 10 citations

Manual for the surveillance of vaccine-preventable diseases. Chapter 5: Human Papillomavirus (HPV)

2011 • 9 citations

HPV vaccines: what remains to be done?

2011 • 9 citations

9-valent HPV (9vHPV) vaccine program key results

2014 • 2 citations

Deleted Work

1955 • 0 citations